Difference between revisions of "ENDO5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
Line 17: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|[[ENDO5:Somatotroph_PitNET/adenoma|Somatotroph PitNET/adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mammosomatotroph_PitNET/adenoma|Mammosomatotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 39:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Lactotroph_PitNET/adenoma|Lactotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 50:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyrotroph_PitNET/adenoma|Thyrotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 45: Line 61:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mature_plurihormonal_PIT1-lineage_PitNET/adenoma|Mature plurihormonal PIT1-lineage PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 72:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Immature_PIT1-lineage_PitNET/adenoma|Immature PIT1-lineage PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 83:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Acidophil_stem_cell_PitNET/adenoma|Acidophil stem cell PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 94:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_somatotroph-lactotroph_PitNET/adenoma|Mixed somatotroph-lactotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 105:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Corticotroph_PitNET/adenoma|Corticotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 116:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gonadotroph_PitNET/adenoma|Gonadotroph PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 127:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Null_cell_PitNET/adenoma|Null cell PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 138:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Plurihormonal_PitNET/adenomas|Plurihormonal PitNET/adenomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 149:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Multiple_synchronous_PitNET/adenomas_of_distinct_lineages|Multiple synchronous PitNET/adenomas of distinct lineages]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 160:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Metastatic_PitNET|Metastatic PitNET]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 171:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 182:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 153: Line 193:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 204:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pituicytomas|Pituicytomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 215:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gangliocytoma_and_mixed_gangliocytoma-PitNET/adenoma|Gangliocytoma and mixed gangliocytoma-PitNET/adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 226:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Sellar_neurocytoma|Sellar neurocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Meningiomas|Meningiomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Chordoma|Chordoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Thyroglossal_duct_cyst|Thyroglossal duct cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Other_congenital_thyroid_abnormalities|Other congenital thyroid abnormalities]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 281:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroid_follicular_nodular_disease|Thyroid follicular nodular disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 198: Line 292:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_adenoma|Follicular thyroid adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 303:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_adenoma_with_papillary_architecture|Follicular thyroid adenoma with papillary architecture]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 314:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Oncocytic_adenoma_of_the_thyroid|Oncocytic adenoma of the thyroid]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 325:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Non-invasive_follicular_thyroid_neoplasm_with_papillary-like_nuclear_features|Non-invasive follicular thyroid neoplasm with papillary-like nuclear features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 336:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroid_tumours_of_uncertain_malignant_potential|Thyroid tumours of uncertain malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 347:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Hyalinizing_trabecular_tumour|Hyalinizing trabecular tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 358:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Follicular_thyroid_carcinoma|Follicular thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 369:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Invasive_encapsulated_follicular_variant_of_papillary_thyroid_carcinoma|Invasive encapsulated follicular variant of papillary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 380:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Papillary_thyroid_carcinoma|Papillary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 391:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Oncocytic_carcinoma_of_the_thyroid|Oncocytic carcinoma of the thyroid]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 402:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:High-grade_follicular_cell-derived_non-anaplastic_thyroid_carcinoma|High-grade follicular cell-derived non-anaplastic thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 413:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Anaplastic_thyroid_carcinoma|Anaplastic thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 424:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Medullary_thyroid_carcinoma|Medullary thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 435:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_medullary_and_follicular_cell-derived_thyroid_carcinomas|Mixed medullary and follicular cell-derived thyroid carcinomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 446:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 457:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Secretory_carcinoma|Secretory carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 468:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Sclerosing_mucoepidermoid_carcinoma_with_eosinophilia|Sclerosing mucoepidermoid carcinoma with eosinophilia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 479:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Cribriform_morular_thyroid_carcinoma|Cribriform morular thyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 490:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thymoma|Thymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 501:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Spindle_epithelial_tumour_with_thymus-like_elements|Spindle epithelial tumour with thymus-like elements]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 512:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Intrathyroidal_thymic_carcinoma|Intrathyroidal thymic carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 523:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Thyroblastoma|Thyroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 534:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_hyperplasia|Parathyroid hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 545:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_adenoma|Parathyroid adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 556:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_lipoadenoma|Parathyroid lipoadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 567:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Atypical_parathyroid_tumour|Atypical parathyroid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 578:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parathyroid_carcinoma|Parathyroid carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 589:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_rests|Adrenal rests]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 600:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cysts|Adrenal cysts]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 611:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_myelolipoma|Adrenal myelolipoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 468: Line 622:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Congenital_adrenal_hyperplasia|Congenital adrenal hyperplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 633:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenocortical_nodular_disease|Adrenocortical nodular disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 644:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cortical_adenoma|Adrenal cortical adenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 655:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_cortical_carcinoma|Adrenal cortical carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 666:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_sex_cord_stromal_tumour|Adrenal sex cord stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 677:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adenomatoid_tumour|Adenomatoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 688:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Adrenal_melanoma|Adrenal melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 699:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Neuroblastoma|Neuroblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 710:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroblastoma,_intermixed|Ganglioneuroblastoma, intermixed]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 721:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroblastoma,_nodular|Ganglioneuroblastoma, nodular]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 732:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Ganglioneuroma|Ganglioneuroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 743:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Phaeochromocytoma|Phaeochromocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 754:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Sympathetic_paraganglioma|Sympathetic paraganglioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 765:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Parasympathetic_paraganglioma|Parasympathetic paraganglioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 776:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Composite_phaeochromocytomas_and_paragangliomas|Composite phaeochromocytomas and paragangliomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 787:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Non-functioning_(non-syndromic)_pancreatic_neuroendocrine_tumours|Non-functioning (non-syndromic) pancreatic neuroendocrine tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 798:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Insulinoma|Insulinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 809:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Glucagonoma|Glucagonoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 820:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Somatostatinoma|Somatostatinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 831:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Gastrinoma|Gastrinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 648: Line 842:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:VIPoma|VIPoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 853:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Serotonin-producing_tumours_with_and_without_carcinoid_syndrome|Serotonin-producing tumours with and without carcinoid syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 864:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Other_pancreatic_neuroendocrine_tumours_with_ectopic_hormone_production|Other pancreatic neuroendocrine tumours with ectopic hormone production]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 875:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Pancreatic_neuroendocrine_carcinoma|Pancreatic neuroendocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 886:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_ductal_adenocarcinoma-neuroendocrine_neoplasms|Mixed ductal adenocarcinoma-neuroendocrine neoplasms]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 693: Line 897:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Mixed_acinar-neuroendocrine_carcinoma|Mixed acinar-neuroendocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 908:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Neuroendocrine_tumours|Neuroendocrine tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 919:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 930:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 941:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[ENDO5:Merkel_cell_carcinoma|Merkel cell carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 952:
 
|
 
|
 
|-
 
|-
 +
|[[ENDO5:Mixed_neuroendocrine-non-neuroendocrine_neoplasms|Mixed neuroendocrine-non-neuroendocrine neoplasms]]
 +
|Disease
 
|
 
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Composite_gangliocytoma/neuroma_and_neuroendocrine_tumour|Composite gangliocytoma/neuroma and neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Lipoma|Lipoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Benign_vascular_tumours|Benign vascular tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:PEComa|PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Glomangioma_and_glomus_tumour|Glomangioma and glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Rhabdomyosarcomas|Rhabdomyosarcomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:IgG4-related_disease|IgG4-related disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Extranodal_marginal_zone_lymphoma|Extranodal marginal zone lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Follicular_dendritic_cell_sarcoma|Follicular dendritic cell sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Germ_cell_tumours_in_endocrine_organs|Germ cell tumours in endocrine organs]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Teratomas_with_endocrine_differentiation|Teratomas with endocrine differentiation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Metastasis_to_the_pituitary_gland|Metastasis to the pituitary gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Metastasis_to_the_thyroid_gland|Metastasis to the thyroid gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Metastasis_to_the_adrenal_gland|Metastasis to the adrenal gland]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_1|Multiple endocrine neoplasia type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_2|Multiple endocrine neoplasia type 2]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_4|Multiple endocrine neoplasia type 4]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Multiple_endocrine_neoplasia_type_5_(MAX-related_tumours)|Multiple endocrine neoplasia type 5 (MAX-related tumours)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Hyperparathyroidism-jaw_tumour_syndrome|Hyperparathyroidism-jaw tumour syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:SDH-deficient_tumour_syndromes|SDH-deficient tumour syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Glucagon_cell_hyperplasia_and_neoplasia|Glucagon cell hyperplasia and neoplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:MAFA-related_familial_insulinomatosis|MAFA-related familial insulinomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Syndromic_familial_follicular_cell-derived_thyroid_tumours|Syndromic familial follicular cell-derived thyroid tumours]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[ENDO5:Non-syndromic_familial_follicular_cell-derived_thyroid_tumours|Non-syndromic familial follicular cell-derived thyroid tumours]]
 
|Disease
 
|Disease
 
|
 
|

Revision as of 14:05, 25 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Endocrine and Neuroendocrine Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Somatotroph PitNET/adenoma Disease
Mammosomatotroph PitNET/adenoma Disease
Lactotroph PitNET/adenoma Disease
Thyrotroph PitNET/adenoma Disease
Mature plurihormonal PIT1-lineage PitNET/adenoma Disease
Immature PIT1-lineage PitNET/adenoma Disease
Acidophil stem cell PitNET/adenoma Disease
Mixed somatotroph-lactotroph PitNET/adenoma Disease
Corticotroph PitNET/adenoma Disease
Gonadotroph PitNET/adenoma Disease
Null cell PitNET/adenoma Disease
Plurihormonal PitNET/adenomas Disease
Multiple synchronous PitNET/adenomas of distinct lineages Disease
Metastatic PitNET Disease
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituitary blastoma Disease
Pituicytomas Disease
Gangliocytoma and mixed gangliocytoma-PitNET/adenoma Disease
Sellar neurocytoma Disease
Meningiomas Disease
Chordoma Disease
Thyroglossal duct cyst Disease
Other congenital thyroid abnormalities Disease
Thyroid follicular nodular disease Disease
Follicular thyroid adenoma Disease
Follicular thyroid adenoma with papillary architecture Disease
Oncocytic adenoma of the thyroid Disease
Non-invasive follicular thyroid neoplasm with papillary-like nuclear features Disease
Thyroid tumours of uncertain malignant potential Disease
Hyalinizing trabecular tumour Disease
Follicular thyroid carcinoma Disease
Invasive encapsulated follicular variant of papillary thyroid carcinoma Disease
Papillary thyroid carcinoma Disease
Oncocytic carcinoma of the thyroid Disease
High-grade follicular cell-derived non-anaplastic thyroid carcinoma Disease
Anaplastic thyroid carcinoma Disease
Medullary thyroid carcinoma Disease
Mixed medullary and follicular cell-derived thyroid carcinomas Disease
Mucoepidermoid carcinoma Disease
Secretory carcinoma Disease
Sclerosing mucoepidermoid carcinoma with eosinophilia Disease
Cribriform morular thyroid carcinoma Disease
Thymoma Disease
Spindle epithelial tumour with thymus-like elements Disease
Intrathyroidal thymic carcinoma Disease
Thyroblastoma Disease
Parathyroid hyperplasia Disease
Parathyroid adenoma Disease
Parathyroid lipoadenoma Disease
Atypical parathyroid tumour Disease
Parathyroid carcinoma Disease
Adrenal rests Disease
Adrenal cysts Disease
Adrenal myelolipoma Disease
Congenital adrenal hyperplasia Disease
Adrenocortical nodular disease Disease
Adrenal cortical adenoma Disease
Adrenal cortical carcinoma Disease
Adrenal sex cord stromal tumour Disease
Adenomatoid tumour Disease
Adrenal melanoma Disease
Neuroblastoma Disease
Ganglioneuroblastoma, intermixed Disease
Ganglioneuroblastoma, nodular Disease
Ganglioneuroma Disease
Phaeochromocytoma Disease
Sympathetic paraganglioma Disease
Parasympathetic paraganglioma Disease
Composite phaeochromocytomas and paragangliomas Disease
Non-functioning (non-syndromic) pancreatic neuroendocrine tumours Disease
Insulinoma Disease
Glucagonoma Disease
Somatostatinoma Disease
Gastrinoma Disease
VIPoma Disease
Serotonin-producing tumours with and without carcinoid syndrome Disease
Other pancreatic neuroendocrine tumours with ectopic hormone production Disease
Pancreatic neuroendocrine carcinoma Disease
Mixed ductal adenocarcinoma-neuroendocrine neoplasms Disease
Mixed acinar-neuroendocrine carcinoma Disease
Neuroendocrine tumours Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Merkel cell carcinoma Disease
Mixed neuroendocrine-non-neuroendocrine neoplasms Disease
Composite gangliocytoma/neuroma and neuroendocrine tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease
Lipoma Disease
Solitary fibrous tumour Disease
Benign vascular tumours Disease
PEComa Disease
Glomangioma and glomus tumour Disease
Angiosarcoma Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Rhabdomyosarcomas Disease
Schwannoma Disease
Neurofibroma Disease
Granular cell tumour Disease
Malignant peripheral nerve sheath tumour Disease
IgG4-related disease Disease
Extranodal marginal zone lymphoma Disease
Diffuse large B-cell lymphoma Disease
Langerhans cell histiocytosis Disease
Rosai-Dorfman disease Disease
Erdheim-Chester disease Disease
Follicular dendritic cell sarcoma Disease
Germ cell tumours in endocrine organs Disease
Teratomas with endocrine differentiation Disease
Metastasis to the pituitary gland Disease
Metastasis to the thyroid gland Disease
Metastasis to the adrenal gland Disease
Multiple endocrine neoplasia type 1 Disease
Multiple endocrine neoplasia type 2 Disease
Multiple endocrine neoplasia type 4 Disease
Multiple endocrine neoplasia type 5 (MAX-related tumours) Disease
Hyperparathyroidism-jaw tumour syndrome Disease
Von Hippel-Lindau syndrome Disease
SDH-deficient tumour syndromes Disease
Neurofibromatosis type 1 Disease
Carney complex Disease
McCune-Albright syndrome Disease
DICER1 syndrome Disease
Glucagon cell hyperplasia and neoplasia Disease
MAFA-related familial insulinomatosis Disease
Syndromic familial follicular cell-derived thyroid tumours Disease
Non-syndromic familial follicular cell-derived thyroid tumours Disease
Retrieved from "https://ccga.io/index.php?title=ENDO5:Volunteer_Assignments_and_Opportunities&oldid=14253"